Brendan Borrell is a freelance journalist based in Los Angeles, California. His stories have appeared in The Atlantic, The New York Times, Bloomberg Businessweek, Outside, National Geographic and many other publications. He is the author of “The First Shots: The Epic Rivalries and Heroic Science Behind the Race to the Coronavirus Vaccine,” and he has a Ph.D. in integrative biology from the University of California, Berkeley.
Brendan Borrell
Contributing writer
From this contributor
Still no proof for facilitated spelling methods
A systematic review into whether the “rapid prompting method” or “spelling to communicate” can help autistic people express themselves comes up empty yet again.
Still no proof for facilitated spelling methods
By
Brendan Borrell
21 May 2026 | 6 min read
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Alzheimer’s scientist forced to retract paper during his own replication effort
Gary Dunbar, a neuroscientist at Central Michigan University, was attempting to redo the 2020 paper after a collaborator admitted to using flawed data in the original work.
Alzheimer’s scientist forced to retract paper during his own replication effort
By
Brendan Borrell
18 July 2025 | 4 min read
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
By
Brendan Borrell, Ellie Kincaid
8 October 2024 | 3 min read
FDA describes ‘objectionable conditions’ at New York State Psychiatric Institute
The facility’s institutional review board failed to report a 2021 incident and “serious and ongoing noncompliance” by a principal investigator, according to a letter released by the federal agency this week.
FDA describes ‘objectionable conditions’ at New York State Psychiatric Institute
By
Brendan Borrell
2 April 2024 | 6 min read
Explore more from The Transmitter
Five new neuroscience books, and other notable titles from 2026
The Transmitter’s summer reading list includes an autopsy of the Human Brain Project, an overview of the neuroscience of motherhood and a memoir from a pioneer in Huntington’s disease research.
Five new neuroscience books, and other notable titles from 2026
The Transmitter’s summer reading list includes an autopsy of the Human Brain Project, an overview of the neuroscience of motherhood and a memoir from a pioneer in Huntington’s disease research.
By
Francisco J. Rivera Rosario
25 August 2026 | 7 min read
Biomarkers for autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 August.
Biomarkers for autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 August.
By
Jill Adams
25 August 2026 | 2 min read
How, when and why to use agentic AI in our neuroscience labs
With agentic AI’s rapid infiltration into science, researchers need to develop AI use policies and practices.
How, when and why to use agentic AI in our neuroscience labs
With agentic AI’s rapid infiltration into science, researchers need to develop AI use policies and practices.
By
Nicolas Schuck
24 August 2026 | 7 min read